bibliographic entry 11912324 [be/11912324]
https://w3id.org/oc/corpus/be/11912324

is a

• bibliographic reference

content

• Herbst, RS, Ansari, R, Bustin, F. Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial, Lancet, 2011, 377, 9780, 1846, 1854, PMID: 21621716

references

• https://w3id.org/oc/corpus/br/349810